These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7122647)

  • 1. [Sustained-release tablets: predominant mechanism of release of a tracer from matrices composed of total and partial glycerides].
    Doelker C; Doelker E
    Pharm Acta Helv; 1982; 57(7):189-92. PubMed ID: 7122647
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlled release of theophylline from inert matrices: effect of channeling material on release rate.
    Ghaly ES; Malavé MI; Rivera WJ; Martí A
    P R Health Sci J; 1993 Dec; 12(4):255-8. PubMed ID: 8140202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained release of drugs by inclusion in plastic matrices. I. Dexchlorpheniramine maleate.
    Alfonso Zerquera HM; Bermudez Benitez E; De Armas Leyva R
    J Pharm Belg; 1983; 38(6):315-9. PubMed ID: 6674474
    [No Abstract]   [Full Text] [Related]  

  • 5. Preparation of sustained release hydrophilic matrices by melt granulation in a high-shear mixer.
    Ochoa L; Igartua M; Hernández RM; Gascón AR; Pedraz JL
    J Pharm Pharm Sci; 2005 Jun; 8(2):132-40. PubMed ID: 16124924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Formulation of slow-release tablets. III. Lipid matrices].
    Doelker E; Buri P
    Pharm Acta Helv; 1981; 56(4-5):111-8. PubMed ID: 7255497
    [No Abstract]   [Full Text] [Related]  

  • 7. Formula optimization based on neural networksin sustained release tablets.
    Wei X; Liang W
    Pharmazie; 2003 Jul; 58(7):521-2. PubMed ID: 12889541
    [No Abstract]   [Full Text] [Related]  

  • 8. Preparation and preliminary evaluation of sustained-release acetylsalicylic acid tablets.
    Jovanović M; Jokić D; Durić Z; Tasić L; Jovicić G
    Pharmazie; 1990 Nov; 45(11):869. PubMed ID: 2100344
    [No Abstract]   [Full Text] [Related]  

  • 9. Sustained delivery of captopril from floating matrix tablets.
    Jiménez-Martínez I; Quirino-Barreda T; Villafuerte-Robles L
    Int J Pharm; 2008 Oct; 362(1-2):37-43. PubMed ID: 18588962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH; Tazeen J; Merchant HA; Yousuf RI
    Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation of sustained - release lithium carbonate matrix tablets: influence of hydrophilic materials on the release rate and in vitro-in vivo evaluation.
    Emami J; Tavakoli N; Movahedian A
    J Pharm Pharm Sci; 2004 Nov; 7(3):338-44. PubMed ID: 15576014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-amylose sodium carboxymethyl starch matrices for oral, sustained drug-release: formulation aspects and in vitro drug-release evaluation.
    Brouillet F; Bataille B; Cartilier L
    Int J Pharm; 2008 May; 356(1-2):52-60. PubMed ID: 18280069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets.
    Li FQ; Hu JH; Deng JX; Su H; Xu S; Liu JY
    Int J Pharm; 2006 Nov; 324(2):152-7. PubMed ID: 16837152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained release phenylpropanolamine hydrochloride from ATO 888 matrix.
    Perez MA; Ghaly ES; Marti A
    P R Health Sci J; 1993 Dec; 12(4):263-7. PubMed ID: 8140204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Formulation of sustained release tablets. I. Inert matrices].
    Salomen JL; Doelker E
    Pharm Acta Helv; 1980; 55(7):174-82. PubMed ID: 7413682
    [No Abstract]   [Full Text] [Related]  

  • 16. [Formulation of sustained-release tablets. II. Hydrophilic matrices].
    Buri P; Doelker E
    Pharm Acta Helv; 1980; 55(7-8):189-97. PubMed ID: 7433467
    [No Abstract]   [Full Text] [Related]  

  • 17. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
    Savaşer A; Ozkan Y; Işimer A
    Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug release of sustained-released tablets of total Puerariae flavones].
    Shi F; Zhu CY
    Zhongguo Zhong Yao Za Zhi; 2008 Jun; 33(12):1396-8. PubMed ID: 18837339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of sustained release hot-melt extruded tablets containing chitosan and xanthan gum.
    Fukuda M; Peppas NA; McGinity JW
    Int J Pharm; 2006 Mar; 310(1-2):90-100. PubMed ID: 16413153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.